ArticleCase reports in oncology

Long-Term Effectiveness and Safety of Isatuximab in Combination with Pomalidomide and Dexamethasone in a Japanese Patient with Refractory Multiple Myeloma and 1q21 Amplification: A Case Report.

Takanori Yoshioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.